-80%

est. 2Y upside i

HealthcareAI & MLSeries A

Automating Healthcare Revenue Cycle Management with AI Workforce

Rank

#3719

Sector

HealthTech, AI

Est. Liquidity

~5Y

Data Quality

Data: Low

This is a high-risk, high-reward early-stage opportunity in a rapidly growing market, but the job seeker must weigh the significant competitive pressures and limited current funding against the potential for substantial upside if the company can effectively scale its proven AI solution.

Last updated: February 15, 2026

Bull (10%)+400%

CombineHealth rapidly scales its proven AI solution, securing significant follow-on funding and expanding its customer base to achieve market leadership in a niche of the growing AI RCM market.

Base (35%)+50%

The company gains moderate traction and secures additional funding, but faces strong competition, leading to steady but not explosive growth.

Bear (55%)-90%

CombineHealth struggles to differentiate against well-funded incumbents and other startups, leading to limited customer acquisition and eventual failure or acquisition at a low valuation.

Est. time to liquidity~5.0 years

Other — 1 role

View all 1 open roles at CombineHealth →

Last updated: March 10, 2026

Community

Valuation Sentiment

Our model estimates -80% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.